Michael K. Porayko

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

Florence Wong, S. Chris Pappas, Michael P. Curry et al. · New England Journal of Medicine · 2021 · 421 citations · Full text

Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation

Ivo Graziadei, Russell H. Wiesner, Kenneth P. Batts et al. · Hepatology · 1999 · 367 citations · Full text

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis

Ivo Graziadei, Russell H. Wiesner, Paul J. Marotta et al. · Hepatology · 1999 · 357 citations · Full text

USE OF FATTY DONOR LIVER IS ASSOCIATED WITH DIMINISHED EARLY PATIENT AND GRAFT SURVIVAL

Willem A. Marsman, Russell H. Wiesner, Rodríguez Luis et al. · Transplantation · 1996 · 304 citations

Fatty Infiltration, Solid Organ Transplantation, Surgery +17